METHODS AND COMPOSITIONS RELATING TO IMPROVED FORMS OF TARGETED ERYTHROPOIETIN

The technology described herein is directed to engineered polypeptides comprising an anti-GYPA antibody reagent and an EPO polypeptide. Further provided herein are methods of treating anemia by administering said polypeptides. La présente invention concerne des polypeptides modifiés comprenant un ré...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEE, Jungmin, WAY, Jeffrey Charles
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The technology described herein is directed to engineered polypeptides comprising an anti-GYPA antibody reagent and an EPO polypeptide. Further provided herein are methods of treating anemia by administering said polypeptides. La présente invention concerne des polypeptides modifiés comprenant un réactif d'anticorps anti-GYPA et un polypeptide EPO. L'invention concerne en outre des méthodes de traitement de l'anémie par administration desdits polypeptides.